Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 10/20 | 0.40 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.40 |
| ▸ | INPP5B | P32019 | 2/20 | 0.39 |
| ▸ | SRC | P12931 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11176606 | 0.80 | — | — | |
| SCHEMBL874930 | 0.68 | — | — | |
| Phosphoric Acid SCHEMBL7209022 | 0.67 | — | — | |
| SCHEMBL669459 | 0.65 | INPPL1 (0.40) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL578121 | 0.64 | — | — | |
| SCHEMBL12050690 | 0.64 | PGK1 (0.45) | — | |
| SCHEMBL11564442 | 0.64 | INPPL1 (0.39) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL28114038 | 0.64 | INPPL1 (0.39) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL16034397 | 0.64 | INPPL1 (0.39) | INPPL1INPP5AAKT1INPP5BSRC | |
| SCHEMBL4181314 | 0.64 | INPPL1 (0.60) | INPPL1INPP5AAKT1INPP5BSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080067-A | Preparation method and application of triazole phosphate type corrosion and scale inhibitor | — | 2026-05-26 | — | — | CN | claimed |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2021-11-16 | — | — | US | claimed |
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2019-05-09 | — | — | US | claimed |
| US-9556294-B2 | Magnetic particle-polymer hybrid materials with functionalized polymers derived from norbornenyl reagents | THE UNIVERSITY OF KANSAS (US) | 2017-01-31 | — | — | US | claimed |
| US-20150175725-A1 | MAGNETIC PARTICLE-POLYMER HYBRID MATERIALS WITH FUNCTIONALIZED POLYMERS DERIVED FROM NORBORNENYL REAGENTS | THE UNIVERSITY OF KANSAS (US) | 2015-06-25 | — | — | US | claimed |
| US-9035003-B2 | High capacity magnetic nanoparticles as supports for reagents and catalysts | THE UNIVERSITY OF KANSAS (US) | 2015-05-19 | — | — | US | claimed |
| US-9029457-B2 | Silica-supported oligomeric hybrid materials | THE UNIVERSITY OF KANSAS (US) | 2015-05-12 | — | — | US | claimed |
| US-20120226007-A1 | HIGH CAPACITY MAGNETIC NANOPARTICLES AS SUPPORTS FOR REAGENTS AND CATALYSTS | THE UNIVERSITY OF KANSAS (US) | 2012-09-06 | — | — | US | claimed |
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | claimed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | claimed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | claimed |
| CN-122080067-A | Preparation method and application of triazole phosphate type corrosion and scale inhibitor | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122080067-A | Preparation method and application of triazole phosphate type corrosion and scale inhibitor | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122080067-A | Preparation method and application of triazole phosphate type corrosion and scale inhibitor | — | 2026-05-26 | — | — | CN | disclosed |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2021-11-16 | — | — | US | disclosed |
| US-20120226007-A1 | HIGH CAPACITY MAGNETIC NANOPARTICLES AS SUPPORTS FOR REAGENTS AND CATALYSTS | THE UNIVERSITY OF KANSAS (US) | 2012-09-06 | — | — | US | disclosed |
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2010-02-04 | — | — | US | disclosed |
| EP-1828217-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | Febit Biotech GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006063717-A2 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | FEBIT BIOTECH GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
| US-5393732-A | Triazole phosphoric acid derivatives and their use as herbicides | ZENECA LIMITED (GB) | 1995-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | APC, CHLSN, MAX | INPPL1 3044/4885INPP5A 2463/4885AKT1 1128/4885 |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | APC, CHLSN, MAX | INPPL1 3044/4885INPP5A 2463/4885AKT1 1128/4885 |
| US-20100029008-A1 | POLYMERASE-INDEPENDENT ANALYSIS OF THE SEQUENCE OF POLYNUCLEOTIDES | POLB, POLM, POLN | INPPL1 1342/4885INPP5A 1513/4885AKT1 4341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.